Wednesday, July 15th, 2020

6:30 am – 5:00 pm

Registration Open

Ballroom Foyer

7:00 am – 8:00 am

Product Theater: A Timely Intervention: Early Clues to Identify the Patient with PsO at Risk of PsA
Continental Breakfast
Sponsored by Novartis (Medical Derm)

Jayme M. Heim, MSN, FNP-BC
Marc J. Serota, MD

Breckenridge

8:00 am – 8:15 am

President’s Address
Jane Glaze, BSN, RN, DNC

Salon E

8:15 am – 9:15 am

GS101: Safe Sunscreens: What to Tell Your Patients (AANP)
This lecture will review the current knowledge regarding the safety of currently utilized sun protective agents, focusing on both organic and inorganic sunscreens. A brief review of the best approach to sun protection in children will also be discussed.
Learning Objectives:
Describe skin diseases correlated to the gut microbiome and effective treatments. Describe the physiology of the skin-gut axis. Describe skin diseases correlated to the gut microbiome and physiology of the skin-gut axis. Compare holistic treatment measures with pharmacological options including the types, dosages, mechanism of action and potential side effects of each.

Sheila Friedlander, MD

Salon E

9:15 am – 10:15 am

GS102: Gut Biome and the Gut-Skin Axis (AANP)
The lecture will explore the mechanisms by which the gut microbiome connects to the rest of the body and the evidence for how gut health and the gut microbiome connects to the skin. The biochemical basis for the gut-skin axis will be discussed along with the evidence for the impact of antibiotics and the use of probiotics within dermatology.
Learning Objective:
Describe skin diseases correlated to the gut microbiome and effective treatments.

Raja Sivamani, MD, MS, AP

Salon E

10:15 am – 12:15 pm

Grand Opening of Exhibit Hall
Join us for the official ribbon cutting ceremony to kick off the opening of the exhibit hall. A wide assortment of products, equipment, and services will be displayed by the leading suppliers of the dermatology industry.

Salon C & D

12:15 pm – 1:30pm

Luncheon Symposium
Title – DUPIXENT® (dupilumab) Product Presentation
Description – Come learn about clinical efficacy, safety information, MOA, dosing and administration, and how DUPIXENT may help your appropriate patients.
Speaker – Victor Czerkasij, MA, MSN, FNP-C
Sponsored by Regeneron Pharmaceuticals and Sanofi Genzyme

Salon A

1:30 pm – 2:30 pm

CS111: Quality of Life in Cutaneous Lymphoma Patients and Families: Emerging Results and Conclusions
This session will explore and analyze the current research related to quality of life issues in patients with cutaneous lymphomas and their caregivers while exploring implications for nursing practice and future research. Didactic and interactive teaching strategies will be utilized.
Learning Objectives:
Identify factors affecting the quality of life in cutaneous lymphoma patients.

Sue McCann, MSN, RN, DNC
Marianne Tawa, MSN, RN, ANP
Susan Thornton

Vail

1:30 pm – 2:30 pm

CS112: Vitiligo: Taking the Surgical Route
Vitiligo is a long-term and non-contagious skin condition that causes the skin to lose its normal color and affects about 1% of the world’s population. Vitiligo can affect a person’s daily life with a negative body image and depression. Melanocyte Keratinocyte Transplantation Procedure (MKTP) is a surgical treatment option for patients with Vitiligo. Melanocytes and Keratinocytes are taken from an area not affected by vitiligo of the patient’s skin and transferred to a recipient site after a solution is prepared. The nurse’s role in this Vitiligo surgical option includes assisting with MKTP, performing cell separation, applying specialized dressings and continuity of care with the patient.
Learning Objectives:
Identify MKTP as a surgical route for Vitiligo and the importance of the nurses role from patient selection to continued continuity of care months to years after surgery.

Kristal Sheffer, BSN, RN

Aspen

1:30 pm – 2:30 pm

CS113: Dermatologic Emergencies (AANP)
Increase your awareness of dermatologic presentations that require an immediate response; Review three ‘red flag’ cutaneous presentations: Erythematous eruption,Erythrodermic eruption, Bullous eruption; Help differentiate between signs and symptoms of serious skin disorders and benign findings (‘red flag’ mimics).
Learning Objectives:
Identify dermatologic presentations that require an immediate response.

Sabrina Newman, MD

Salon E

2:30 pm – 4:00 pm

Exhibits Open/Poster Viewing

Salon C & D

4:00 pm – 5:00pm

CS121: Rediscovering Professional Nursing Certification
In 1998, dermatology nurses sat for the first certification exam written specifically for the practice of dermatology nursing. In 2020, we will celebrate 22 years of dermatology certification. This presentation will explore all aspects of certification including its place in the current health care culture.
Learning Objectives:
Discuss the historical roots of certification in specialty nursing practice.
Identify the constructs of certification that validate dermatology nursing practice.
Identify the processes and benefits of certification.


Sue McCann, MSN, RN, DNC
Trudy Adamson, MSN, RN, DNC
Kathy Gross, RN, DNC
Sandra Walsh, MScN, RN, DNC
Ana Wiley, NP
Janina Rukavina, BSN, RN, DNC

Aspen

4:00 pm – 5:00pm

CS122: Atypical Leg Wounds and Dermatological Nursing: Climbing to New Heights (AANP)
Leg wounds are often classified based on their etiologies, such as neuropathy, vascular insufficiency, and prolonged pressure. However, not all wounds fall neatly into these categories. It is estimated that approximately 10% of chronic leg wounds are considered atypical, meaning they are the result of an etiology other than neuropathy, vascular insufficiency, or pressure. The purpose of this presentation will be to provide health care clinicians at any level with information to enhance their understanding of atypical leg wounds and to apply principles of wound care toward treatment. Target audience will include nurses at all levels of licensure including but not limited to LPN/LVN, RN, and APRN.
Learning Objectives:
Identify atypical lower leg wounds based on assessment and clinical manifestations with focus on treatment applications and wound dressing categories. Identify atypical leg wounds based on assessment and clinical manifestations. Differentiate between the different types of wound dressings and their mechanisms of action including clinical application and frequency of usage.

Jessica Simmons, MSN, APRN, FNP-C, CWOBm, DNC

Salon E

4:00 pm – 5:00pm

CS123: How To Have An Unforgettable Positive Office Visit
This session focuses on what it is like to be a dermatology nurse in these trying times in medicine and gives powerfully satisfying answers on how to make each day unforgettably positive. With individual and group discussions, and with the accenting of these discussions with prosaic sayings and poetry, we will all leave refreshed, knowing that we are not alone, that we have control, and that we have the answers to making our professional and personal lives even more precious… to make each day…unforgettably positive.
Learning Objectives:
Express what a perfect day would look like. Define what gets in the way of that perfect day.
Identify how to make better, those disturbing influences on one’s day.

Steven Shama,MD, MPH, FAAD
Tena Brown

Vail

5:00 pm – 6:00 pm

Product Theater: Uncovering Clearn SKYRIZI for adults with moderate to severe plaque psoriasis
Wine and Cheese Served
Sponsored by Abbvie

Lakshi Aldredge, MSN, ANP-BC

Breckenridge

5:00 pm – 6:00 pm

Product Theater: Cutaneous Melanoma and DecisionDx®-Melanoma
Wine and Cheese Served
Sponsored by Castle Biosciences

Shannon Trotter, DO

Steamboat

6:00 pm – 7:00 pm

First-Time Attendee Reception
All first-time attendees are welcome. Join the DNA Board of Directors and the Program Planning Committee for refreshments while networking with DNA leaders. Please select this event when completing your registration.

Telluride

7:00 pm – 10:00 pm

DNA Dance Party with DJ Bella Scratch

Silverton